ON DEMAND: Delaying diabetic CKD progression – the role of finerenone

10 Aug 2023

Watch again as an expert panel discusses a different approach to the challenge of CKD in diabetes. Featuring updates and commentary on key trial data, guidance on the use of finerenone in practice and discussion of its place in combination treatment and standard of care in Australia.

Hosted by Professor Jonathan Shaw
Deputy Director (Clinical and Population Health), Baker Heart & Diabetes Institute; Professor in the School of Life Sciences, La Trobe University; Professor in the School of Public Health and Preventive Medicine, Monash University.


Professor Peter Rossing. Professor in Diabetic Angiopathy, University of Copenhagen; Research Leader, Complications Research, Steno Diabetes Centre, Copenhagen.

Professor Elif Ekinci. Director, Diabetes, Austin Health; Director, the Australian Centre for Accelerating Diabetes Innovations (ACADI); Clinician Researcher and Academic Endocrinologist, The University of Melbourne.

Dr Brendon Neuen. Staff Specialist Nephrologist and Director, Kidney Trials Unit, Royal North Shore Hospital; Senior Research Fellow, The George Institute for Global Health. 

For more information, please contact [email protected].


This event was  supported by an unrestricted educational grant and created independently by the limbic in collaboration with the Australian Diabetes Society, the host and panel. All studies are selected by the panel and all views expressed are those of the host and panel only.ADS

Already a member?

Login to keep reading.

Email me a login link